Cancer News

Discover the latest advancements in prevention, early detection, research, treatment, products and services for those affected by cancer and involved in treatment. This section includes organizations raising awareness and funds for cancer research, companies developing technology and medications for cancer treatment and legal and public policy announcements related to carcinogens and cancer care.

Tigerlily Foundation Launches Comprehensive Program to Support Young Women with Metastatic Breast Cancer

Tigerlily Foundation is excited to announce the re-design and launch of its Metastatic Young (MY) Living in Focus Empowered (LIFE) program offerings to provide comprehensive programming to meet the unique needs of younger women living with metastatic breast cancer (MBC). Although women over 45... - April 26, 2016 - Tigerlily Foundation

Dr. James Gulley - NCI, NIH to Speak at the Cancer Immunotherapy Congress in Boston

Dr. James Gulley, an internationally recognized expert in cancer immunotherapy has joined the speaker panel for the Cancer Immunotherapy Congress organized by Markets and Markets Conferences. The congress scheduled for 19th – 20th May 2016 in Boston, USA, will gather scientists, academicians... - April 22, 2016 - MarketsandMarkets

Voicebrook to Exhibit at the 2016 Soft Network Users Group (SNUG)

Company to demonstrate how Pathologists can take control over their diagnostic reports with VoiceOver and SCC's AP System offerings. - April 15, 2016 - Voicebrook, Inc.

Mesothelioma Victims Center Now Offers Tips About Why Full-Time Experience Matters When It Comes to Hiring a Mesothelioma Lawyer

The Mesothelioma Victims Center says, "Because mesothelioma is such a rare form of cancer, it should go without saying that if a recently diagnosed person with mesothelioma, or their family, the chances of losing out on compensation are high if they do not have representation from one of the... - April 14, 2016 - Mesothelioma Victims Center

The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada

Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.

One Night Only - A Night of Fashion

A Night of Fashion to... have fun, be inspired by guest speakers, win incrediable door prizes, feel warmth, hear extravagant melodies from Ashthon Jones, Angelina Sherie, and Cristina Quinones, witness exquisite fashion, want to support a breast cancer survivor even more, share a smile, indulge in laughter, network with several business and industry professionals, sample amazing food, indulge in a beverage, and support a great cause all at the same time, for One Night Only. - April 12, 2016 - I Will Survive, Inc.

Mesothelioma Victims Center Offers to Guide a Diagnosed US Navy Veteran Through the Mesothelioma Compensation Process to Ensure the Best Settlement

The Mesothelioma Victims Center says, "We want to educate all US Navy Veterans recently diagnosed with mesothelioma and/or their family about the compensation process. We also want to include shipyard and manufacturing workers in this group because they typically know exactly how or where they... - April 07, 2016 - Mesothelioma Victims Center

Ex-Journalist Launches Website to Connect Families to Senior Advocates for Help Finding Assisted Living

Tony’s Rolodex refers families to trusted Senior Placement Advocates for help finding Assisted Living and Memory Care. It is launching first in Arizona and Florida. Advocates provide an alternative to the services of such Senior Housing Referral websites as A Place for Mom and Caring.com. - April 07, 2016 - Tony's Rolodex LLC

Cancer Transitions Workshop Series Helps Cancer Survivors Thrive

Cancer Support Community Central New Jersey Expands Free Survivorship Program to Three Locations - April 02, 2016 - Cancer Support Community Central New Jersey

Belluck & Fox Mesothelioma Victims Center Now Points to Young Adults Getting Mesothelioma with an Offer to Help All Diagnosed People Get Better Treatment and Compensation

The Belluck & Fox Mesothelioma Victims Center says, "We help people who have been diagnosed with mesothelioma anywhere in the nation get the best possible compensation for this rare form of cancer, and we also specialize in doing the research for the best nearby hospitals for treatment. - March 31, 2016 - Mesothelioma Victims Center

Midwest Young Adult Cancer Conference Gilda’s Club Offers Free Public Conference for Those Impacted by a Cancer Diagnosis Before 40

On Saturday, April 2 from 9am to 4pm, Gilda’s Club Madison is hosting the Midwest Young Adult Cancer Conference to help individuals and families address the unique challenges of those diagnosed with cancer under the age of 40. - March 31, 2016 - Gilda's Club Madison

Video Series Educates Families on Brain Tumors

In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation

BBB Wise Giving Alliance Urges Vigilant Donations Following Government Settlement with Fraudulent Cancer Charities

BBB Wise Giving Alliance Urges Vigilant Donations Following Government with Fraudulent Cancer Charities; BBB WGA Offers Tips to Keep Donors Safe and Secure. - March 30, 2016 - BBB Wise Giving Alliance

Belluck & Fox Mesothelioma Victims Center Now Urges Diagnosed Shipyard Workers and Navy Veterans Nationwide to Call for Honest Financial Compensation Advice

The Belluck & Fox Mesothelioma Victims Center says, "We want all recently diagnosed shipyard workers and/or US Navy Veterans to call us anytime at 800-714-0303 for extremely honest advice about the needed components for the best possible financial compensation for this cancer caused by... - March 28, 2016 - Mesothelioma Victims Center

Belluck & Fox Mesothelioma Victims Center Urges Recently Diagnosed Persons to Call Them About the Best Possible Compensation and Information on New Treatment Options

The Belluck & Fox Mesothelioma Victims Center is urging all individuals recently diagnosed with mesothelioma to call them anytime at 800-714-0303 to get clarity on what is involved in a mesothelioma compensation claim, as well as extremely good advice about where they should be receiving their... - March 24, 2016 - Mesothelioma Victims Center

Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests

Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix

RVA Arts Community Launches “Impressions of Courage,” A World Record Honoring Those Affected by Cancer

A press conference in Scott's Addition this Thursday will preview the biggest arts undertaking Richmond, Va has ever seen - a 1000-foot collograph to honor those whose lives have been affected by cancer. - March 24, 2016 - Art on Wheels

Belluck & Fox Mesothelioma Victims Center Now Urges a Diagnosed US Navy Veteran to Call Them About Vital Compensation Tips

The Belluck & Fox Mesothelioma Victims Center says, "If a US Navy Veteran or their family members have recently learned of a confirmed mesothelioma diagnosis, the last thing we want to have happen is for them to get lost in the maze of confusing Internet advertising related to mesothelioma. - March 21, 2016 - Mesothelioma Victims Center

Carevive to Kickoff Survivorship Care Planning at Jefferson University

The Sidney Kimmel Cancer Center at Jefferson will use a novel platform to delivery survivorship care plans. By using Carevive’s Care Planning System (CPS), Jefferson will be able to provide personalized survivorship care plans to its patients across multiple tumor types. The Carevive CPS will integrate with Jefferson’s electronic health record (EHR) and registry software. - March 21, 2016 - Carevive Systems

Diet Doc Places More Focus on Eliminating Cancer Causing High-Glycemic Carbohydrates to Reduce the Risk of Carbohydrate-Related Lung Cancer

Diet Doc continues to help patients lose 20 or more pounds per month while reducing the risk of weight-related disease, now including carbohydrate-related lung cancer. - March 16, 2016 - Diet Doc

New Party Game Provides Entertaining Option for Breast Cancer Chemo Support

POP Qs Pink Power party game encourages and supports a growing trend in the American breast cancer community. - March 16, 2016 - POP Qs Party Games

Mesothelioma Victims Must Have the Best Lawyers for Better Compensation and They Are Urged to Call the Belluck & Fox Mesothelioma Victims for Optimal Results

The Belluck & Fox Mesothelioma Victims Center says, "We assist people nationwide who have been diagnosed with mesothelioma get the best possible financial settlements. We do this with a very hands-on approach where we spend as much time as possible with the diagnosed person in their home... - March 14, 2016 - Mesothelioma Victims Center

New Podcast “Market Forces Impacting Oncology Care in the U.S.” Now Available on WorldCongress.com

Celldex Therapeutics’ Senior Director, Market Access, Reg Waldeck, PhD, outlines a few of the market forces impacting oncology care in the United States and what can be learned from what is done abroad in new podcast available on the World Congress website. The podcast is geared toward... - March 09, 2016 - World Congress

Honored VIP Member, Susan J. Littman, Recognized by America’s Registry of Outstanding Professionals as Professional of the Year 2016

Dr. Susan J. Littman of Ambler, Pennsylvania was selected as Professional of the Year 2016 in Oncology by America’s Registry of Outstanding Professionals. - March 04, 2016 - America's Registry of Outstanding Professionals

Belluck & Fox Mesothelioma Victims Center Now Provides Vital Legal Tips for a Diagnosed US Navy Veteran and Their Family for a Much Better Settlement

The Belluck & Fox Mesothelioma Victims Center is now offering no nonsense legal tips formulated to help a US Navy Veteran who has been diagnosed with mesothelioma anywhere in the nation to ensure they much better mesothelioma compensation. The Center says, "We can’t overemphasize... - March 03, 2016 - Mesothelioma Victims Center

ALFA Scientific Sponsors San Diego Race for Colon Cancer Awareness

Leading Developer of Rapid Medical Tests Joins Forces with the Colon Cancer Alliance - March 02, 2016 - Alfa Scientific

FLAG Therapeutics Announces the Granting of Orphan Drug Designation to FLAG-003 in Both the US and EU for the Treatment of Glioma

FLAG Therapeutics Inc. announced today that the U.S. Food and Drug Administration’s Office of Orphan Products Development and the European Medicines Agency (EMA) have both granted Orphan Drug Designation to FLAG-003 for the treatment of glioma. Gliomas (including Glioblastoma) are the most... - March 02, 2016 - FLAG Therapeutics

Belluck & Fox Mesothelioma Victims Center Now Offers a Vital New Service to Ensure a Person with This Cancer Understands How the Compensation Process Works

The Belluck & Fox Mesothelioma Victims Center says, "We want to make certain that a person who has been diagnosed with mesothelioma understands how the mesothelioma claim process actually works. We do everything possible to keep it as simple as possible for the victim and family. The first... - February 29, 2016 - Mesothelioma Victims Center

Study: New Drug Found to Further Boost Survival for Advanced Prostate Cancer Patients, According to PiscoMed's Oncology Journal AMOR

Adrenal inhibitor abiraterone acetate provides more substantial advantages in treating metastatic cases - February 29, 2016 - PiscoMed Publishing Pte Ltd

Delivering the Cancer Strategy Conference - Thursday, 28 April 2016 – Central London

Investigate methods to enhance prevention, transform support for patients living with and beyond cancer and ensure your organisation has the tools to offer the highest quality care and services. - February 27, 2016 - Capita Conferences

Data Bridge Market Research Has Added a New Market Report on "Global Cancer Biomarkers Market – Analysis and Forecast 2012 – 2020"

Global Cancer Biomarkers Market Trends and Forecast to 2020 - by Tumor (Breast, Lung, Prostate), by Type (Protein & Genetic Biomarkers), by Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), by Application (Diagnostic, Drug Discovery, Prognostic). - February 23, 2016 - Data Bridge Market Research

Belluck & Fox Mesothelioma Victims Center Now Provides the Most Experienced Attorneys to Represent a Diagnosed US Navy Veteran and Their Family-Nationwide

The Belluck & Fox Mesothelioma Victims Center says, "We are 100% devoted to the proposition that a US Navy Veteran, or any person for that matter who has been diagnosed with mesothelioma receives the very best possible compensation for this cancer caused by asbestos exposure. We have put... - February 22, 2016 - Mesothelioma Victims Center

Data Bridge Market Research Has Added a New Market Report on "Global Cancer Diagnostics Market – Analysis and Forecast 2012 – 2020"

Cancer Diagnostics Market Trends and Forecast to 2020 - By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma) & By Geography - February 19, 2016 - Data Bridge Market Research

PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016

DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016 - DelveInsight

Information Experts Sponsors Tigerlily Foundation

Tigerlily Foundation is pleased to welcome a new sponsor, Information Experts, to its Corporate Circle of Strength. Over the past 20 years, Information Experts has established itself as a powerful partner for Strategic Communications. They are award-winning and recognized as trusted leaders in the... - February 13, 2016 - Tigerlily Foundation

Kubtec: Improving Precision and Breast Cancer Outcomes with RSL

For women, testing positive for breast cancer arouses a host of uncertainties: loss of a breast, disfigurement and worse. Oftentimes, the rush to remove all cancer takes precedence over breast conservation, both for patients and surgeons, in an effort to ensure all cancer cells are... - February 12, 2016 - Kubtec

Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens

Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.

Accredited Chronic Lymphocytic Leukaemia CME Module Launches on EPGonline.org

A new online CME module is now available in the Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre on epgonline.org. This activity is intended for haematology/oncology specialists and other healthcare professionals involved in the treatment of patients with CLL. CLL is the most common form of... - February 11, 2016 - EPG Health Media

NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter

NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect

Super Bowl Fundraising Campaign to Support Children Battling Cancer in Denver and Charlotte

Be Brave Foundation is launching a Super Bowl Fundraising campaign in hopes of supporting children and families battling pediatric cancer in Charlotte & Denver. The campaign pits the fan bases of the Denver Broncos and Carolina Panthers against one another for an amazing cause. - January 30, 2016 - Be Brave Foundation

Teen Cancer America and Roger Daltrey to Host North Carolina Cares Benefit April 28

The Who Frontman And Nonprofit’s Co-Founder To Help Raise Funds For Specialized Teenage Cancer Care Units Throughout North Carolina - January 27, 2016 - Teen Cancer America

PRIMO and Cancer Action Now, Inc. Honors Women in Oncology

The Practical Recommendations in Immuno and Molecular Oncology (PRIMO) meeting sponsored by Cancer Action Now, Inc. announces that Suzanne Topalian, MD from Johns Hopkins University and Ranjana Tavorath, MD from Novartis have been honored with the meetings first ever Women in Oncology award. - January 18, 2016 - Cancer Expert Now, Inc.

Maine’s Oldest Ski Area Races to Fight Childhood Cancer

The Maine Children's Cancer Program is holding its second annual ski and snowboard "moonlight challenge" race at Shawnee Peak. On Friday, January 22nd, race to win exciting prizes and to help raise funds to treat hundreds of local Maine children. - January 13, 2016 - MCCP

3D Breast Cancer Specimen Imaging – The Future is Now

Breast cancer imaging results can be greatly improved upon with 3D specimen radiography, a new advance in breast cancer treatment offered exclusively by Kubtec. - January 10, 2016 - Kubtec

Insight Global Gives Back

Insight Global, a Staffing Services Company, has done its part to give back to the community. In 2015, every Insight Global branch participated in at least one service project benefiting a charity or organization of its choice. In addition to three companywide fundraisers held throughout the course... - January 06, 2016 - Insight Global

H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors

H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.

The Providence Community is Top Fundraiser in Most-Attended Worldwide Making Strides Against Breast Cancer Event

Providence Golf and Country Club Community, located in a natural setting just southwest of Orlando, is a growing development of neighborhoods by ABD Development and other large builders. This community’s Making Strides Against Breast Cancer fundraising team, the “Providence Booby Brigade,” raised the highest amount of money at the Orlando Making Strides Against Breast Cancer walk of any non-corporate team in 2015. Brand new homes are currently available for sale within Providence. - December 31, 2015 - ABD Development Company